- Sepsis Awareness: Advancing Timely Diagnosis
- Lessons Learned: What the Cyclospora Outbreak
- Protecting Food. Protecting People.
- Annual Report: Achievements Building a Healthier Future
- AMR is Rising — Stewardship Demands Global Leadership
News
For patients at risk of sepsis, time matters. Faster diagnostic information can help healthcare teams identify the cause of infection sooner, supporting earlier better-informed care decisions.
Swipe for more stories
-
First-Half 2026 Results
bioMérieux's Q2 2026 sales totaled €981 million, with solid organic growth at +5%, reaching +7% excluding BIOFIRE® respiratory panels. The sales of the GO•28 growth drivers increased by 8.5% organically in Q2 26. -
bioMérieux Highlights Positive Impacts of Rapid, Accurate Diagnostics for Patients and Accepts Industry Awards at ADLM 2026
bioMérieux hosted a press panel and accepted seven 2026 IMV ServiceTrak™ Clinical Laboratory Awards. These awards highlight bioMérieux’s continued commitment to delivering industry-leading diagnostic solutions and exceptional customer support to clinical laboratories. -
Lessons Learned: What the Cyclospora Outbreak Teaches Us About the Importance of Accurate Diagnostics
This summer’s cyclospora outbreak brought with it an opportunity for learning best practices and a reminder that surveillance monitoring and community data can help healthcare providers, municipalities, and government agencies be ready for the next outbreak.
Enabling Decision-Making
- BIOMÉRIEUX+
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19
- BIOMÉRIEUX+
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19